Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 4 Comparative Analysis of Clinical Events for Diabetic Patients Treated With Drug-Eluting Stents in Registries Enrolling Similar Populations
(A) Likelihood of target vessel revascularization (PES vs. SES) (n = 5,542 diabetic patients). (B) Likelihood of major adverse cardiac events (PES vs. SES) (n = 5,006 diabetic patients). Size of boxes indicates relative contribution of each study. See Table 2 for further details regarding registries included. C REWARDS = Cypher Registry Experience at the Washington Hospital Center With Drug-Eluting Stents; RESEARCH/T-SEARCH = Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries; SOLACI = Society of Latin American Interventional Cardiologists registry; STENT = Strategic Transcatheter Evaluation of New Therapies group; T REWARDS = Taxus Registry Experience at the Washington Hospital Center With Drug-Eluting Stents; TC-WYRE = The Taxus Cypher "What's Your Real-World Experience" study; other abbreviations as in Figure 2.
|
